Vakalyuk II, Virstyuk NG. Diagnostic significance of the newest biomarkers of steatosis progression in patients with stable coronary heart disease, combined with nonalcoholic fatty liver disease. Current issues in pharmacy and medicine: science and practice [Internet]. 2018Feb.16 [cited 2024May3];(1). Available from: http://pharmed.zsmu.edu.ua/article/view/123648